Found 7 matching trials
Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO PHASE2 This prospective, randomized, controlled pilot trial aims to assess the saf...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. PHASE3 Patients with hereditary antithrombin (AT) deficiency are at increased risk...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO PHASE4 Maintenance of adequate anticoagulation or blood thinning is of critical im...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia PHASE3 The purpose of the study is to assess the efficacy, safety and pharmacokine...
Show More Location
University of Alabama
Learn More & Join Trial
Antithrombin III Concentrate After Liver Transplantation NA This study was designed to demonstrate more effective administration method...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery PHASE3 Patients with hereditary antithrombin deficiency are at increased risk of v...
Show More Location
Multiple Locations
Learn More & Join Trial
Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients EARLY_PHASE1 The objective of this study will be to prospectively evaluate the response ...
Show More Location
Multiple Locations
Learn More & Join Trial